Bezogene Services
Anzeige:
h3>GlycoVaxyn is a clinical stage biopharmaceutical company focused on the development and manufacture of next-generation bioconjugate vaccines utilizing its proprietary recombinant DNA technology. ; 20.06.12 GlycoVaxyn to Present at the 2012 BIO International Convention 02.04.12 GlycoVaxyn to Present at the 2nd Annual Vaccines Congress 2012 28.03.12 GlycoVaxyn to Present at the World Congress of Vaccine 2012 ;
GlycoVaxyn will be present during:
- the 2012 BIO International Convention in Boston on June 18-21, 2012 (presenting)
- the World Vaccines Congress Asia 2012 in Singapore on June 11-14, 2012
- the World Vaccine Congress in Washington on April 10-13, 2012
;
;
Copyright © 2010 GlycoVaxyn. All rights reserved. Disclaimer | Glossary
Anzeige: